-
- Erratum in:
- Pediatr Rev 2002 Jan;23(1): 1 p.
Hemolytic-uremic syndrome.
The hemolytic-uremic syndrome (HUS) has been recognized for more than 45 years and consists of the combination of hemolytic anemia, thrombocytopenia, and acute renal failure. HUS occurs predominantly in children younger than 4 years of age. It is the most frequent cause of acute renal failure in children. The most common form of the syndrome (D+ HUS) occurs in healthy young children (>6 mo to <5 y of age) and is preceded by watery diarrhea that can evolve to hemorrhagic colitis. The diarrhea precedes the hemolysis and thrombocytopenia by 5 to 7 days; oliguria/anuria follows several days later. Although the pathogenesis is unknown, available evidence strongly suggests that endothelial cell damage is necessary. The outcome for most patients who have D+ HUS is favorable: 65% to 85% recover completely, 5% to 10% die (usually during the acute illness), recurrence is uncommon, and only a few patients slowly progress to end-stage renal disease (ESRD).
PMID: 11691946 [PubMed - indexed for MEDLINE]
-
Cited by 4 PubMed Central articles
-
p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells.
Stone MK, Kolling GL, Lindner MH, Obrig TG.
Infect Immun. 2008 Mar; 76(3):1115-21. Epub 2007 Dec 17.
[Infect Immun. 2008]
-
Association of Escherichia coli O157:H7 tir polymorphisms with human infection.
Bono JL, Keen JE, Clawson ML, Durso LM, Heaton MP, Laegreid WW.
BMC Infect Dis. 2007 Aug 24; 7:98. Epub 2007 Aug 24.
[BMC Infect Dis. 2007]
-
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function.
Guessous F, Marcinkiewicz M, Polanowska-Grabowska R, Kongkhum S, Heatherly D, Obrig T, Gear AR.
Infect Immun. 2005 Dec; 73(12):8306-16.
[Infect Immun. 2005]
- » See all...